1 |
Priyadarshini, K., Kulandhaivel, M., Sankareswaran, M. and Anbalagan, S. 2021. In-vitro screening of reverse tran- scriptase activity of selected Indian medicinal plants against human immunodeficiency virus type-1. Eur. J. Mol. Clin. Med. 7, 5168-5175.
|
2 |
Dutta, T., Baildya, N., Khan, A. A. and Ghosh, N. N. 2021. Inhibitory effect of anti-HIV compounds extracted from Indian medicinal plants to retard the replication and tran- scription process of SARS-CoV-2: an insight from molec- ular docking and MD-simulation studies. Netw. Model. Anal. Health Inform. Bioinform. 10, 1-11.
DOI
|
3 |
Wu, H. F., Morris-Natschke, S. L., Xu, X. D., Yang, M. H., Cheng, Y. Y., Yu, S. S. and Lee, K. H. 2020. Recent advances in natural anti-HIV triterpenoids and analogs. Med. Res. Rev. 40, 2339-2385.
DOI
|
4 |
Pan, B., Li, S., Xiao, J., Yang, X., Xie, S., Zhou, Y., Yang, J. and Wei, Y. 2022. Dual inhibition of HIV-1 and cathe- psin L proteases by Sarcandra glabra. Molecules 27, 5552.
|
5 |
Gulick, R. M. and Flexner, C. 2019. Long-acting HIV drugs for treatment and prevention. Annu. Rev. Med. 70, 137-150.
DOI
|
6 |
Kaur, R., Sharma, P., Gupta, G. K., Ntie-Kang, F. and Kumar, D. 2020. Structure-activity-relationship and mech- anistic insights for anti-HIV natural products. Molecules 25, 2070.
|
7 |
Yin, Z. H., Yan, H. L., Pan, Y., Zhang, D. W. and Yan, X. 2022. Evaluation of a flavonoid library for inhibition of interaction of HIV-1 integrase with human LEDGF/p75 towards a structure-activity relationship. Ann. Med. 54, 1590-1600.
DOI
|
8 |
Zubair, M. S., Khairunisa, S. Q., Widodo, A., Nasronudin. and Pitopang, R. 2021. Antiviral screening on Alpinia ere- mochlamys, Etlingera flexuosa, and Etlingera acanthoides extracts against HIV-infected MT-4 cells. Heliyon 7, e06710.
|
9 |
Langarizadeh, M. A., Abiri, A., Ghasemshirazi, S., Foroutan, N., Khodadadi, A. and Faghih-Mirzaei, E. 2021. Phlor- otannins as HIV Vpu inhibitors, an in silico virtual screening study of marine natural products. Biotechnol. Appl. Biochem. 68, 918-926.
DOI
|
10 |
Maia, C. M. de A., Pasetto, S., Silva, J. P. R. e., Tavares, J. F., Costa, E. M. M. de B. and Murata, R. M. 2021. Anandenanthera colubrina (Vell.) Brenan as an inhibitor of HIV-1 BaL infection. Nat. Prod. Res. 36, 1621-1625.
|
11 |
Rotich, W., Mas-Claret, E., Sadgrove, N., Guantai, A., Padilla-Gonzalez, G. F. and Langat, M. K. 2022. HIV-1 integrase inhibitory effects of major compounds present in CareVidTM : An anti-HIV multi-herbal remedy. Life 12, 417.
|
12 |
Sanna, C., Marengo, A., Acquadro, S., Caredda, A., Lai, R., Corona, A., Tramontano, E., Rubiolo, P. and Esposito, F. 2021. In vitro anti-HIV-1 reverse transcriptase and integrase properties of Punica granatum L. leaves, bark, and peel extracts and their main compounds. Plants 10, 2124.
|
13 |
Sillapachaiyaporn, C., Rangsinth, P., Nilkhet, S., Moung- kote, N. and Chuchawankul, S. 2021. HIV-1 protease and reverse transcriptase inhibitory activities of Curcuma aeru- ginosa Roxb. rhizome extracts and the phytochemical profile analysis: In vitro and in silico screening. Pharmaceuti- cals 14, 1115.
|
14 |
Zheng, Y., Yang, X. W., Schols, D., Mori, M., Botta, B., Chevigne, A., Mulinge, M., Steinmetz, A., Schmit, J. C. and Seguin-Devaux, C. 2021. Active components from Cassia abbreviata prevent HIV-1 entry by distinct mecha- nisms of action. Int. J. Mol. Sci. 22, 5052.
|
15 |
Panvilai, S., Napaswad, C., Limthongkul, J. and Akkar- awongsapat, R. 2020. Aqueous extracts of Thai medicinal plants possess anti-HIV-1 activity. J. Herbs. Spices Med. Plants 27, 1-10.
|
16 |
Syed, I. A., Sulaiman, S. A. S., Hassali, M. A., Thiruchel- vam, K., Syed, S. H. and Lee, C. K. C. 2016. Beliefs and practices of complementary and alternative medicine (CAM) among HIV/AIDS patients: A qualitative exploration. Eur. J. Integr. Med. 8, 41-47.
|
17 |
WHO 1989. In vitro screening of traditional medicines for anti-HIV activity: memorandum from a WHO meeting. Bull. World Health Organ. 67, 613-618.
|
18 |
Olwenyi, O. A., Asingura, B., Naluyima, P., Anywar, G. U., Nalunga, J., Nakabuye, M., Semwogerere, M., Bagaya, B., Cham, F., Tindikahwa, A., Kiweewa, F., Lichter, E. Z., Podany, A. T., Fletcher, C. V., Byrareddy, S. N. and Kibuuka, H. 2021. In-vitro Immunomodulatory activity of Azadirachta indica A. Juss. ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion. BMC Complement. Med. Ther. 21, 1-14.
DOI
|
19 |
Vora, J., Velhal, S., Sinha, S., Patel, V. and Shrivastava, N. 2021. Bioactive phytocompound mulberroside C and endophytes of Morus alba as potential inhibitors of HIV-1 replication: a mechanistic evaluation. HIV Med. 22, 690-704.
DOI
|
20 |
Terefe, E. M., Okalebo, F. A., Derese, S., Muriuki, J., Rotich, W., Mas-Claret, E., Sadgrove, N., Padilla-Gonzalez, G. F., Prescott, T. A. K., Siddique, H. and Langat, M. K. 2022. Constituents of Croton megalocarpus with potential anti-HIV activity. J. Nat. Prod. 85, 1861-1866.
DOI
|
21 |
Andersen, R. J., Ntie-Kang, F. and Tietjen, I. 2018. Natural product-derived compounds in HIV suppression, remis- sion, and eradication strategies. Antiviral Res. 158, 63-77.
DOI
|
22 |
Bertagnolio, S., Jordan, M. R., Giron, A. and Inzaule, S. 2022. Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergence. Curr. Opin. HIV AIDS 17, 229-239.
DOI
|
23 |
Cary, D. C. and Peterlin, B. M. 2018. Natural products and HIV/AIDS. AIDS Res. Hum. Retroviruses 34, 31-38.
DOI
|
24 |
Fois, B., Corona, A., Tramontano, E., Distinto, S., Maccioni, E., Meleddu, R., Caboni, P., Floris, C. and Cottiglia, F. 2021. Flavonoids and acid-hydrolysis derivatives of neo- clerodane diterpenes from Teucrium flavum subsp. glau- cum as inhibitors of the HIV-1 reverse transcriptase-asso- ciated RNase H function. J. Enzyme Inhib. Med. Chem. 36, 749-757.
DOI
|
25 |
Tumilaar, S. G., Fatimawali, F., Niode, N. J., Effendi, Y., Idroes, R., Adam, A. A., Rakib, A., Bin Emran, T. and Tallei, T. E. 2021. The potential of leaf extract of Pangium edule Reinw as HIV-1 protease inhibitor: A computational biology approach J. Appl. Pharm. Sci. 11, 101-110.
|
26 |
Koch, M. A., Schuffenhauer, A., Scheck, M., Wetzel, S., Casaulta, M., Odermatt, A., Ertl, P. and Weldmann, H. 2005. Charting biologically relevant chemical space: A structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. USA. 102, 17272-17277.
DOI
|
27 |
Guzzo, F., Russo, R., Sanna, C., Celaj, O., Caredda, A., Corona, A., Tramontano, E., Fiorentino, A., Esposito, F. and D'abrosca, B. 2021. Chemical characterization and anti-HIV-1 activity assessment of iridoids and flavonols from Scrophularia trifoliata. Molecules 26, 4777.
|
28 |
Harb, T. B. and Chow, F. 2022. Anti-HIV activity of meth- anolic and aqueous extracts of fifteen materials of beachcast macroalgae: valorization of underused waste biomass. Appl. Phycol. 3, 236-246.
DOI
|
29 |
Kharisma, V. D., Kharisma, S. D., Ansori, A. N. M., Kurniawan, H. P., Witaningrum, A. M., Fadholly, A. and Tacharina, M. R. 2021. Antiretroviral effect simulation from black tea (Camellia sinensis) via dual inhibitors mechanism in HIV-1 and ITS SOCIAL PERSPECTIVE IN Indonesia. Res. J. Pharm. Technol. 14, 455-460.
DOI
|
30 |
Li, G., Wang, Y. and De Clercq, E. 2022. Approved HIV reverse transcriptase inhibitors in the past decade. Acta Pharm. Sin. B 12, 1567-1590.
DOI
|
31 |
Lu, D. Y., Wu, H. Y., Yarla, N. S., Xu, B., Ding, J. and Lu, T. R. 2017. HAART in HIV/AIDS treatments: Future trends. Infect. Disord. Drug Targets 18, 15-22.
|
32 |
Messi, A. N., Bonnet, S. L., Owona, B. A., Wilhelm, A., Kamto, E. L. D., Ndongo, J. T., Siwe-Noundou, X., Poka, M., Demana, P. H., Krause, R. W. M., Mbing, J. N., Peg- nyemb, D. E. and Bochet, C. G. 2022. In vitro and in silico potential inhibitory effects of new biflavonoids from Ochna rhizomatosa on HIV-1 integrase and Plasmodium falciparum. Pharmaceutics 14, 1701.
|
33 |
Sierra-Aragon, S. and Walter, H. 2012. Targets for in- hibition of HIV replication: Entry, enzyme action, release and maturation. Intervirology 55, 84-97.
DOI
|
34 |
Murali, M., Gowtham, H. G., Ansari, M. A., Alomary, M. N., Alghamdi, S., Almehmadi, M., Singh, S. B., Shilpa, N., Aiyaz, M., Kalegowda, N., Ledesma, A. E. and Amruthesh, K. N. 2022. Repositioning therapeutics for SARSCoV-2: Virtual screening of plant-based anti-HIV com- pounds as possible inhibitors against COVID-19 viral RdRp. Curr. Pharm. Des. 28, 969-980.
DOI
|
35 |
Popovic-Djordjevic, J., Quispe, C., Giordo, R., Kostic, A., Katanic Stankovic, J. S., Tsouh Fokou, P. V., Carbone, K., Martorell, M., Kumar, M., Pintus, G., Sharifi-Rad, J., Docea, A. O. and Calina, D. 2022. Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs. Eur. J. Med. Chem. 233, 114217.
|